Compile Data Set for Download or QSAR
Report error Found 105 Enz. Inhib. hit(s) with all data for entry = 10584
LigandPNGBDBM552587(WO2022098970, Example 335)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552586(WO2022098970, Example 330)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552587(WO2022098970, Example 335)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552587(WO2022098970, Example 335)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552581(WO2022098970, Example 317)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552581(WO2022098970, Example 317)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552582(WO2022098970, Example 318)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552582(WO2022098970, Example 318)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552583(WO2022098970, Example 321)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552582(WO2022098970, Example 318)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552583(WO2022098970, Example 321)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552583(WO2022098970, Example 321)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552584(WO2022098970, Example 324)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552584(WO2022098970, Example 324)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552585(WO2022098970, Example 329)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552584(WO2022098970, Example 324)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552585(WO2022098970, Example 329)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552585(WO2022098970, Example 329)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552586(WO2022098970, Example 330)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552586(WO2022098970, Example 330)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552555(WO2022098970, Example 3)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552554(WO2022098970, Example 2 | WO2022098970, Example 9)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552555(WO2022098970, Example 3)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552555(WO2022098970, Example 3)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552556(WO2022098970, Example 4)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552556(WO2022098970, Example 4)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552557(WO2022098970, Example 5)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552556(WO2022098970, Example 4)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552557(WO2022098970, Example 5)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552557(WO2022098970, Example 5)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552558(WO2022098970, Example 6)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552558(WO2022098970, Example 6)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552559(WO2022098970, Example 7)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552558(WO2022098970, Example 6)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552559(WO2022098970, Example 7)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552559(WO2022098970, Example 7)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552553(WO2022098970, Example 1)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552553(WO2022098970, Example 1)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552553(WO2022098970, Example 1)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552554(WO2022098970, Example 2 | WO2022098970, Example 9)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552554(WO2022098970, Example 2 | WO2022098970, Example 9)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552565(WO2022098970, Example 199)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552565(WO2022098970, Example 199)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552566(WO2022098970, Example 221)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552566(WO2022098970, Example 221)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552567(WO2022098970, Example 222)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552566(WO2022098970, Example 221)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552567(WO2022098970, Example 222)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552567(WO2022098970, Example 222)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

LigandPNGBDBM552568(WO2022098970, Example 292)
Affinity DataIC50: 150nMAssay Description:Compounds of formulas I, la to lx, Ila to IIx, and/or Illa to IIIx are screened for their ability to inhibit wildtype, V804M, and G810S mutant RET ki...More data for this Ligand-Target Pair
In Depth
Date in BDB:
8/7/2022
Entry Details
WIPO WO2022098970

Displayed 1 to 50 (of 105 total ) | Next | Last >>
Jump to: